-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $170

Benzinga·12/22/2025 13:05:06
语音播报
Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $160 to $170.